Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
47.98
+0.34 (0.71%)
Apr 20, 2026, 10:33 AM EDT - Market open

Medline Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
63,03134,104---
Enterprise Value
73,62253,198000
Last Close Price
47.9842.00---
PE Ratio
33.49-4200.00---
PS Ratio
2.201.20---
PB Ratio
3.603.18---
P/TBV Ratio
3.623.17---
P/FCF Ratio
49.5126.29---
P/OCF Ratio
35.8919.56---
EV/Sales Ratio
2.591.87---
EV/EBITDA Ratio
23.0816.51---
EV/EBIT Ratio
33.7924.05---
EV/FCF Ratio
58.2541.02---
Debt / Equity Ratio
0.650.650.990.97-
Debt / EBITDA Ratio
3.903.905.287.50-
Debt / FCF Ratio
9.699.6911.6611.71-
Net Debt / Equity Ratio
0.990.991.010.89-
Net Debt / EBITDA Ratio
3.303.305.226.80-
Net Debt / FCF Ratio
8.198.1911.5210.61-
Asset Turnover
0.760.760.711.29-
Inventory Turnover
4.534.534.489.10-
Quick Ratio
2.202.201.402.12-
Current Ratio
4.294.293.394.13-
Return on Equity (ROE)
6.46%6.46%7.16%2.76%-
Return on Assets (ROA)
5.51%5.51%5.73%6.13%-
Return on Invested Capital (ROIC)
6.07%6.07%6.27%6.81%-
Return on Capital Employed (ROCE)
6.36%6.36%6.36%7.35%-
Earnings Yield
1.85%-0.02%---
FCF Yield
2.02%3.80%---
Dividend Yield
-1.52%---
Payout Ratio
-44.69%126.50%48.72%-92.00%
Buyback Yield / Dilution
95.36%----
Total Shareholder Return
95.36%1.52%---
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q